期刊文献+

抗病毒抗生素17997体外抗HIV及体内抗SIV活性的研究 被引量:5

THE EFFECTS OF ANTIVIRAL ANTIBIOTIC 17997 AGAINST HIV-1 IN VITRO AND SIV IN VIVO
下载PDF
导出
摘要 17997为由我国云南省土壤中分离的一株链霉菌所产生的广谱抗病毒抗生素。在淋巴细胞培养内,17997对人免疫缺陷病毒I型(HIV-1)不同株有抑制活性,IC50为0.018~0.15μM,与叠氮胸苷(AZT)耐药株无交叉耐药,且与AZT有协同作用。在猴免疫缺陷病毒(SIV)急性感染的恒河猴模型内,腹腔给药及皮下给药均能降低血浆内病毒滴度,缩短病毒血症时间,以腹腔给药效果较皮下给药佳且有量效关系。结果说明17997在实验条件下有抗SIV感染作用。 is a broad spectrum antiviral antibiotic produced by a strain of streptomyces isolated from a soil sample collected in Yunnan Province of China.17997 displayed inhibitory effects on deferent strains of human immunodefficiency virus type 1(HIV-1)in deferent cell lines with IC 50 of 0.018-0.15μM.AZT resistant strain of HIV1 is still sensitive to 17997 without cross resistance.In cell culture both 17997 and AZT are synergistic against HIV1.In vivo experiment rhesus monkeys were infected by Simian Immunodeficiency Virus(SIVmac 251)and treatment by 17997 via ip or sc once a day for 22 days.The results showed that 17997 treatment could reduce the serum virus titers and shorten the period of viruemia.Theeffcacy of 17997 treatment by ip rout was better than did by sc rout.It also showed dose-efficacy relationship. This indicated that 17997 could inhibit SIV replication in the experiment conditions. \
出处 《中国性病艾滋病防治》 1997年第6期271-274,共4页 Chinese Journal of Std & Aids Prevention and Control
基金 国家自然科学基金主任基金
关键词 抗病毒抗生素 人免疫缺陷病毒 猴免疫缺陷病毒 Antiviral antibiotic 17997 Human Immunodefficiency Virus Simian Immunodefficiency Virus
  • 相关文献

同被引文献22

  • 1程春雷,游雪甫,王跃明,张伟新,娄人慧,陈慧贞,李电东,蒋建东.固相萃取-HPLC法研究格尔德霉素在Beagle犬药代动力学[J].药物分析杂志,2005,25(4):409-412. 被引量:4
  • 2佘高宏,孟志云,刘慧玲,王东援,窦桂芳.反相HPLC法测定大鼠血浆中17-烯丙胺基-17-脱甲基格尔德霉素及其代谢产物17-氨基-17-脱甲基格尔德霉素[J].药物分析杂志,2005,25(10):1161-1164. 被引量:1
  • 3陶佩珍.抗病毒药物临床应用的进展[J].北京医药,1995,(1):21-29.
  • 4Agnew EB, Wilson RH, Grem JL, et al. Measurement of the novel antitumor agent 17-( allylamino )-17-demethoxygel danamycin in human plasma by high-performance liquid chromatography[J ] .J Chromatogr B ,2001,755(1 - 2) :237 - 243.
  • 5Indu PK, Manjit S, Meenakshi K, et al. Formulation and evalution of ophthalmic preparations of acetazolamide [ J ]. Int J Pharm ,2000,199(2): 119 - 127.
  • 6Felt O, Furrer P, Mayer JM, et al. Topical use of chitosan in ophthalmology: tolerance assessment and evaluation of precorneal retion[J]. Int J Pharm ,1999,180(2): 185 - 193.
  • 7Edmund G. Biopharmaceutical availability of sulphadicramide from ocular ointments in vitro [J]. Eur J Pharm Sci, 1998,6 (3) :247 - 253.
  • 8陶佩珍,北京医药,1995年,1/2期,21页
  • 9Nechkers L. Hsp90 inhibitors as novel cancer chemotherapy agents[J]. Trends Mol Med, 2002, 8:S55
  • 10Rascher A, Hu Z, Viswanathan N, et al. Cloning and characterization of a gene cluster for geldanamycin production in Streptomyces hygroscopicus NRRI3602[J]. FEMS Microbiol Lett,2003,218(2): 223

引证文献5

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部